BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26226902)

  • 21. Germline mutations in Japanese familial pancreatic cancer patients.
    Takai E; Yachida S; Shimizu K; Furuse J; Kubo E; Ohmoto A; Suzuki M; Hruban RH; Okusaka T; Morizane C; Furukawa T
    Oncotarget; 2016 Nov; 7(45):74227-74235. PubMed ID: 27732944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort.
    Schwartz M; Korenbaum C; Benfoda M; Mary M; Colas C; Coulet F; Parrin M; Jonveaux P; Ingster O; Granier S; De Mestier L; Cros J; Riffault A; Muller M; Levy P; Rebours V; Greenhalf W; Soufir N; Hammel P
    Clin Genet; 2019 Dec; 96(6):579-584. PubMed ID: 31432501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progress report: familial pancreatic cancer.
    Mintziras I; Bartsch DK
    Fam Cancer; 2019 Jul; 18(3):359-362. PubMed ID: 30796632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Familial pancreatic cancer--current knowledge.
    Bartsch DK; Gress TM; Langer P
    Nat Rev Gastroenterol Hepatol; 2012 Aug; 9(8):445-53. PubMed ID: 22664588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
    Aslanian HR; Lee JH; Canto MI
    Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Cystic Lesions by Secondary Screening of Familial Pancreatic Cancer (FPC) Kindreds Is Not Associated with the Stratified Risk of Cancer.
    Sheel ARG; Harrison S; Sarantitis I; Nicholson JA; Hanna T; Grocock C; Raraty M; Ramesh J; Farooq A; Costello E; Jackson R; Chapman M; Smith A; Carter R; Mckay C; Hamady Z; Aithal GP; Mountford R; Ghaneh P; Hammel P; Lerch MM; Halloran C; Pereira SP; Greenhalf W
    Am J Gastroenterol; 2019 Jan; 114(1):155-164. PubMed ID: 30353057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial pancreatic cancer: challenging diagnostic approach and therapeutic management.
    Mastoraki A; Chatzimavridou-Grigoriadou V; Chatzipetrou V; Mastoraki S; Papanikolaou IS; Danias N; Smyrniotis V; Arkadopoulos N
    J Gastrointest Cancer; 2014 Sep; 45(3):256-61. PubMed ID: 24756831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BRCA2 mutations as a universal risk factor for pancreatic cancer has a limited role in Korean ethnic group.
    Cho JH; Bang S; Park SW; Chung JB; Song SY
    Pancreas; 2008 May; 36(4):337-40. PubMed ID: 18437078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer.
    Ohmoto A; Yachida S; Morizane C
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
    Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J
    Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications and issues related to familial pancreatic cancer: a cohort study of hospitalized patients.
    Mughetti M; Calculli L; Chiesa AM; Ciccarese F; Rrusho O; Pezzilli R
    BMC Gastroenterol; 2016 Jan; 16():6. PubMed ID: 26767414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
    Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
    Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Familial pancreatic cancer].
    Zalatnai A
    Magy Onkol; 2006; 50(2):163-8. PubMed ID: 16888680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer surveillance awareness and practice among families at increased risk for pancreatic adenocarcinoma.
    Everett JN; Burgos G; Chun J; Baptiste A; Khanna LG; Oberstein PE; Simeone DM
    Cancer; 2021 Jul; 127(13):2271-2278. PubMed ID: 33721345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial?
    Torphy RJ; Schulick RD
    Surg Clin North Am; 2018 Feb; 98(1):25-35. PubMed ID: 29191275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.
    Goehringer C; Sutter C; Kloor M; Gebert J; Slater EP; Keller M; Treiber I; Ganschow P; Kadmon M; Moog U
    Fam Cancer; 2017 Apr; 16(2):303-309. PubMed ID: 27838800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
    Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
    Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer.
    Takai E; Nakamura H; Chiku S; Kubo E; Ohmoto A; Totoki Y; Shibata T; Higuchi R; Yamamoto M; Furuse J; Shimizu K; Takahashi H; Morizane C; Furukawa T; Yachida S
    Ann Surg; 2022 Apr; 275(4):e652-e658. PubMed ID: 32826389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.
    Furniss CS; Yurgelun MB; Ukaegbu C; Constantinou PE; Lafferty CC; Talcove-Berko ER; Schwartz AN; Stopfer JE; Underhill-Blazey M; Kenner B; Nelson SH; Okumura S; Law S; Zhou AY; Coffin TB; Rodriguez NJ; Uno H; Ocean AJ; McAllister F; Lowy AM; Lippman SM; Klein AP; Madlensky L; Petersen GM; Garber JE; Goggins MG; Maitra A; Syngal S
    Cancer Prev Res (Phila); 2021 Nov; 14(11):1021-1032. PubMed ID: 34625409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BRCA2 germline mutations in familial pancreatic carcinoma.
    Hahn SA; Greenhalf B; Ellis I; Sina-Frey M; Rieder H; Korte B; Gerdes B; Kress R; Ziegler A; Raeburn JA; Campra D; Grützmann R; Rehder H; Rothmund M; Schmiegel W; Neoptolemos JP; Bartsch DK
    J Natl Cancer Inst; 2003 Feb; 95(3):214-21. PubMed ID: 12569143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.